Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Candidiasis, Esophageal clinical trials
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Candidiasis, Esophageal: 4 US clinical trials tracked, none currently recruiting.
Candidiasis, Esophageal is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Janssen Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition candidiasis-esophageal
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Candidiasis, Esophageal has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Candidiasis, Esophageal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Candidiasis, Esophageal is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis
Merck Sharp & Dohme
NCT00005921
Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients
Bristol-Myers Squibb
NCT00002041
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
Janssen Pharmaceuticals
NCT00002132
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
Pfizer
NCT00002304
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Candidiasis, Esophageal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Candidiasis, Esophageal trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Candidiasis, Esophageal page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Candidiasis, Esophageal trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Janssen Pharmaceuticals sponsors the most Candidiasis, Esophageal trials on record, review their full trial history before evaluating a specific study. See Janssen Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Candidiasis, Esophageal condition card totals 4 registered trials; most-linked intervention Fluconazole; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.